HAYWARD, Calif.--(BUSINESS WIRE)--Aradigm Corporation (NASDAQ:ARDM) (the “Company”) today announced financial results for the fourth quarter and full year ended December 31, 2014.
Fourth Quarter 2014 Results
The Company recorded $8.1 million in revenue in the fourth quarter of 2014 compared with $4.6 million in revenue in the fourth quarter of 2013. Total operating expenses for the fourth quarter of 2014 were $8.9 million, compared with total operating expenses of $4.9 million for the fourth quarter of 2013. The increase in operating expenses was primarily due to higher research and development expenses related to the Pulmaquin® inhaled ciprofloxacin program. The Company’s net loss for the fourth quarter of 2014 was $0.8 million, or $0.06 per share, compared with a net loss of $0.7 million, or $0.04 per share, for the same period in 2013.
Help employers find you! Check out all the jobs and post your resume.
Help employers find you! Check out all the jobs and post your resume.
